Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma

Simple item page
dc.contributor.authorArmstrong, Andrew J.
dc.contributor.authorNixon, Andrew B.
dc.contributor.authorCarmack, Andrea
dc.contributor.authorYang, Qian
dc.contributor.authorEisen, Tim
dc.contributor.authorStadler, Walter M.
dc.contributor.authorJones, Robert J.
dc.contributor.authorGarcia, Jorge A.
dc.contributor.authorVaishampayan, Ulka N.
dc.contributor.authorPicus, Joel
dc.contributor.authorHawkins, Robert E.
dc.contributor.authorHainsworth, John D.
dc.contributor.authorKollmannsberger, Christian K.
dc.contributor.authorLogan, Theodore F.
dc.contributor.authorPuzanov, Igor
dc.contributor.authorPickering, Lisa M.
dc.contributor.authorRyan, Christopher W.
dc.contributor.authorProtheroe, Andrew
dc.contributor.authorGeorge, Daniel J.
dc.contributor.authorHalabi, Susan
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2022-11-22T17:48:30Z
dc.date.available2022-11-22T17:48:30Z
dc.date.issued2021-06
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationArmstrong, A. J., Nixon, A. B., Carmack, A., Yang, Q., Eisen, T., Stadler, W. M., Jones, R. J., Garcia, J. A., Vaishampayan, U. N., Picus, J., Hawkins, R. E., Hainsworth, J. D., Kollmannsberger, C. K., Logan, T. F., Puzanov, I., Pickering, L. M., Ryan, C. W., Protheroe, A., George, D. J., & Halabi, S. (2021). Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma. Clinical Cancer Research, 27(12), 3503–3503. https://doi.org/10.1158/1078-0432.CCR-21-1636en_US
dc.identifier.issn1078-0432, 1557-3265en_US
dc.identifier.urihttps://hdl.handle.net/1805/30606
dc.language.isoen_USen_US
dc.publisherAACRen_US
dc.relation.isversionof10.1158/1078-0432.CCR-21-1636en_US
dc.relation.journalClinical Cancer Researchen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectAngiokinesen_US
dc.subjectEverolimus Treatmenten_US
dc.subjectNon–Clear Cell Renal Cell Carcinomaen_US
dc.titleCorrection: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinomaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Armstrong2021Correction-AAM.pdf
Size:
107.13 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works